| Year |
Citation |
Score |
| 2024 |
Serrano-Villar S, Gala A, Bacchetti P, Hoh R, di Germanio C, Cohn LB, Henrich TJ, Hunt PW, Laird GM, Pillai SK, Deeks SG, Peluso MJ. Galectin-9 Levels as a Potential Predictor of Intact HIV Reservoir Decay. The Journal of Infectious Diseases. PMID 39207259 DOI: 10.1093/infdis/jiae426 |
0.303 |
|
| 2024 |
Bouzidi MS, Dossani ZY, Benedetto CD, Raymond KA, Desai S, Chavez LR, Betancur P, Pillai SK. High-resolution Inference of Multiplexed Anti-HIV Gene Editing using Single-Cell Targeted DNA Sequencing. Biorxiv : the Preprint Server For Biology. PMID 38328062 DOI: 10.1101/2024.01.24.576921 |
0.362 |
|
| 2023 |
Sperber HS, Raymond KA, Bouzidi MS, Ma T, Valdebenito S, Eugenin EA, Roan NR, Deeks SG, Winning S, Fandrey J, Schwarzer R, Pillai SK. The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. Cell Reports. 42: 113285. PMID 37910505 DOI: 10.1016/j.celrep.2023.113285 |
0.337 |
|
| 2023 |
Premeaux TA, Yeung ST, Pillai SK, Ndhlovu LC. Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states. Journal of Neurovirology. PMID 37233903 DOI: 10.1007/s13365-023-01149-9 |
0.343 |
|
| 2021 |
Egedal JH, Xie G, Packard TA, Laustsen A, Neidleman J, Georgiou K, Pillai SK, Greene WC, Jakobsen MR, Roan NR. Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection. Mucosal Immunology. PMID 33976386 DOI: 10.1038/s41385-021-00409-3 |
0.368 |
|
| 2021 |
Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, ... ... Pillai SK, et al. Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity . Journal of Virology. PMID 33536176 DOI: 10.1128/JVI.02393-20 |
0.308 |
|
| 2020 |
Rutishauser RL, Deguit CDT, Hiatt J, Blaeschke F, Roth TL, Wang L, Raymond KA, Starke CE, Mudd JC, Chen W, Smullin CP, Matus-Nicodemos R, Hoh R, Krone MR, Hecht FM, ... ... Pillai SK, et al. TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. Jci Insight. PMID 33351785 DOI: 10.1172/jci.insight.136648 |
0.331 |
|
| 2020 |
Sperber HS, Togarrati PP, Raymond KA, Bouzidi MS, Gilfanova R, Gutierrez AG, Muench MO, Pillai SK. μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32901981 DOI: 10.1096/Fj.202001612Rr |
0.465 |
|
| 2020 |
Vallejo-Gracia A, Chen IP, Perrone R, Besnard E, Boehm D, Battivelli E, Tezil T, Krey K, Raymond KA, Hull PA, Walter M, Habrylo I, Cruz A, Deeks S, Pillai S, et al. FOXO1 promotes HIV latency by suppressing ER stress in T cells. Nature Microbiology. PMID 32541947 DOI: 10.1038/S41564-020-0742-9 |
0.449 |
|
| 2020 |
Marques de Menezes EG, Jang K, George AF, Nyegaard M, Neidleman J, Inglis HC, Danesh A, Deng X, Afshari A, Kim YH, Billaud JN, Marson K, Pilcher CD, Pillai SK, Norris PJ, et al. Seminal plasma-derived extracellular vesicle fractions from HIV-infected men exhibit unique miRNA signatures and induce a pro-inflammatory response in cells isolated from the female reproductive tract. Journal of Virology. PMID 32434889 DOI: 10.1128/Jvi.00525-20 |
0.472 |
|
| 2019 |
Li Z, Wu J, Chavez L, Hoh R, Deeks SG, Pillai SK, Zhou Q. Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency. Plos Pathogens. 15: e1007498. PMID 30645648 DOI: 10.1371/Journal.Ppat.1007498 |
0.488 |
|
| 2019 |
Sperber H, Togarrati PP, Raymond K, Bouzidi MS, Gilfanova R, Muench MO, Pillai SK. μ-Lat: a high-throughput humanised mouse model of latent HIV infection Journal of Virus Eradication. 5: 19. DOI: 10.1016/S2055-6640(20)30119-9 |
0.442 |
|
| 2019 |
Sperber H, Ma T, Roan NR, Pillai SK. Expression profiling of HIV latently-infected cells using nanostring and mass cytometry Journal of Virus Eradication. 5: 1. DOI: 10.1016/S2055-6640(20)30070-4 |
0.433 |
|
| 2018 |
Premeaux TA, D'Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Gisslén M, Price RW, Valcour V, Ndhlovu LC. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. Journal of Neurovirology. PMID 30478799 DOI: 10.1007/S13365-018-0696-3 |
0.458 |
|
| 2018 |
Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Tojal Da Silva I, Cohn LB, Gramatica A, Deeks S, Greene WC, Pillai SK, Verdin E. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4 T Cells. Elife. 7. PMID 29714165 DOI: 10.7554/Elife.34655 |
0.469 |
|
| 2018 |
Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Silva ITD, Cohn LB, Gramatica A, Deeks S, Greene WC, Pillai SK, Verdin E. Author response: Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells Elife. DOI: 10.7554/Elife.34655.028 |
0.415 |
|
| 2018 |
Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Da Silva IT, Cohn LB, Gramatica A, Deeks S, Greene W, Pillai SK, Verdin E. D-106 Chromatin Functional States Correlate with the Reversal of Latently HIV-1 Infected Primary CD4+ T cells Jaids Journal of Acquired Immune Deficiency Syndromes. 77: 40. DOI: 10.1097/01.Qai.0000532598.61340.64 |
0.407 |
|
| 2017 |
Bangirana P, Ruel TD, Boivin MJ, Pillai SK, Giron LB, Sikorskii A, Banik A, Achan J. Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy. Journal of the International Aids Society. 20. PMID 29052340 DOI: 10.1002/Jia2.25015 |
0.421 |
|
| 2017 |
Krarup AR, Abdel-Mohsen M, Schleimann MH, Vibholm L, Engen PA, Dige A, Wittig B, Schmidt M, Green SJ, Naqib A, Keshavarzian A, Deng X, Olesen R, Petersen AM, Benfield T, ... ... Pillai SK, et al. The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. Mucosal Immunology. PMID 28766555 DOI: 10.1038/Mi.2017.59 |
0.391 |
|
| 2017 |
Henrich TJ, Deeks SG, Pillai SK. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies. The Journal of Infectious Diseases. 215: S134-S141. PMID 28520968 DOI: 10.1093/Infdis/Jiw648 |
0.44 |
|
| 2017 |
Pillai SK, Deeks SG. Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed. Trends in Immunology. PMID 28511815 DOI: 10.1016/J.It.2017.04.007 |
0.452 |
|
| 2017 |
Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP. HIV Antibodies Detect HIV Persistence and Low Level Viral Replication. The Journal of Infectious Diseases. PMID 28498985 DOI: 10.1093/Infdis/Jix225 |
0.464 |
|
| 2017 |
Vibholm L, Schleimann MH, Højen JF, Benfield T, Offersen R, Rasmussen K, Olesen R, Dige A, Agnholt J, Grau J, Buzon M, Wittig B, Lichterfeld M, Petersen AM, Deng X, ... ... Pillai SK, et al. Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28329286 DOI: 10.1093/Cid/Cix201 |
0.402 |
|
| 2017 |
Oussayef NL, Pillai SK, Honein MA, Ben Beard C, Bell B, Boyle CA, Eisen LM, Kohl K, Kuehnert MJ, Lathrop E, Martin SW, Martin R, McAllister JC, McClune EP, Mead P, et al. Zika Virus -10 Public Health Achievements in 2016 and Future Priorities. Mmwr. Morbidity and Mortality Weekly Report. 65: 1482-1488. PMID 28056005 DOI: 10.15585/Mmwr.Mm6552E1 |
0.302 |
|
| 2017 |
Jacobs ES, Keating SM, Abdel-Mohsen M, Gibb SL, Heitman JW, Inglis HC, Martin JN, Zhang J, Kaidarova Z, Deng X, Wu S, Anastos K, Crystal H, Villacres MC, Young M, ... ... Pillai SK, et al. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression. Journal of Virology. PMID 28053103 DOI: 10.1128/Jvi.02051-16 |
0.479 |
|
| 2017 |
Munoz-Arias I, Hanhauser E, Hogan L, Mohsen MA, Hobbs K, Thanh C, Gibson E, Deeks SG, Pillai SK, Henrich TJ. OA2-3 Small-molecule chemotherapeutic drugs reactivate HIV-1 via non-canonical pathways and modulate CD8 T cell response Journal of Virus Eradication. 3: 2-3. DOI: 10.1016/S2055-6640(20)30837-2 |
0.378 |
|
| 2016 |
Abdel-Mohsen M, Chavez L, Tandon R, Chew GM, Deng X, Danesh A, Keating S, Lanteri M, Samuels ML, Hoh R, Sacha JB, Norris PJ, Niki T, Shikuma CM, Hirashima M, ... ... Pillai SK, et al. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation. Plos Pathogens. 12: e1005677. PMID 27253379 DOI: 10.1371/Journal.Ppat.1005677 |
0.496 |
|
| 2015 |
Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. Aids (London, England). 29: 411-20. PMID 25602681 DOI: 10.1097/Qad.0000000000000572 |
0.592 |
|
| 2015 |
Giron LB, Tenore S, Sucupira MCA, Janini LM, Pillai S, Diaz RS. Evidence of ongoing HIV replication during suppressive antiretroviral therapy Journal of Virus Eradication. 1: 29-30. DOI: 10.1016/S2055-6640(20)31370-4 |
0.436 |
|
| 2014 |
Abdel-Mohsen M, Deng X, Danesh A, Liegler T, Jacobs ES, Rauch A, Ledergerber B, Norris PJ, Günthard HF, Wong JK, Pillai SK. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo. Plos One. 9: e109220. PMID 25275557 DOI: 10.1371/Journal.Pone.0109220 |
0.409 |
|
| 2014 |
Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF. Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo. Journal of Virology. 88: 11624-9. PMID 25031350 DOI: 10.1128/Jvi.01771-14 |
0.411 |
|
| 2014 |
Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy. The Journal of Infectious Diseases. 210: 1838-43. PMID 24935955 DOI: 10.1093/Infdis/Jiu338 |
0.584 |
|
| 2014 |
Abdel-Mohsen M, Deng X, Liegler T, Guatelli JC, Salama MS, Ghanem Hel-D, Rauch A, Ledergerber B, Deeks SG, Günthard HF, Wong JK, Pillai SK. Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo. Journal of Virology. 88: 763-7. PMID 24155399 DOI: 10.1128/Jvi.02687-13 |
0.453 |
|
| 2013 |
Abdel-Mohsen M, Raposo RA, Deng X, Li M, Liegler T, Sinclair E, Salama MS, Ghanem Hel-D, Hoh R, Wong JK, David M, Nixon DF, Deeks SG, Pillai SK. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology. 10: 106. PMID 24131498 DOI: 10.1186/1742-4690-10-106 |
0.444 |
|
| 2013 |
Raposo RA, Abdel-Mohsen M, Bilska M, Montefiori DC, Nixon DF, Pillai SK. Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells. Journal of Virology. 87: 11924-9. PMID 23966394 DOI: 10.1128/Jvi.02128-13 |
0.458 |
|
| 2013 |
Raposo RA, Abdel-Mohsen M, Holditch SJ, Kuebler PJ, Cheng RG, Eriksson EM, Liao W, Pillai SK, Nixon DF. Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. Journal of Leukocyte Biology. 94: 1051-9. PMID 23929683 DOI: 10.1189/Jlb.0313150 |
0.419 |
|
| 2013 |
Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, ... ... Pillai S, et al. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. Plos Pathogens. 9: e1003347. PMID 23671416 DOI: 10.1371/Journal.Ppat.1003347 |
0.595 |
|
| 2012 |
Pillai SK, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene WC, Kovari H, Rauch A, Fellay J, Battegay M, Hirschel B, Witteck A, Bernasconi E, et al. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proceedings of the National Academy of Sciences of the United States of America. 109: 3035-40. PMID 22315404 DOI: 10.1073/Pnas.1111573109 |
0.472 |
|
| 2011 |
Skasko M, Tokarev A, Chen CC, Fischer WB, Pillai SK, Guatelli J. BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology. 411: 65-77. PMID 21237475 DOI: 10.1016/J.Virol.2010.12.038 |
0.319 |
|
| 2010 |
Rempel H, Sun B, Calosing C, Pillai SK, Pulliam L. Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. Aids (London, England). 24: 1415-23. PMID 20495440 DOI: 10.1097/Qad.0B013E32833Ac623 |
0.422 |
|
| 2010 |
Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, Ignacio CC, Russell T, Pillai SK, Looney DJ, Dandekar S. In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. Plos Pathogens. 6: e1000748. PMID 20126442 DOI: 10.1371/Journal.Ppat.1000748 |
0.352 |
|
| 2010 |
Manosuthi W, Butler DM, Pérez-Santiago J, Poon AF, Pillai SK, Mehta SR, Pacold ME, Richman DD, Pond SK, Smith DM. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. Aids (London, England). 24: 411-6. PMID 20009919 DOI: 10.1097/Qad.0B013E3283350Eef |
0.698 |
|
| 2010 |
Joos B, Rieder P, Fischer M, Kuster H, Rusert P, Trkola A, Pillai SK, Wong JK, Weber R, Günthard HF. Association between specific HIV-1 Env traits and virologic control in vivo. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 10: 365-72. PMID 19524069 DOI: 10.1016/J.Meegid.2009.06.002 |
0.473 |
|
| 2009 |
Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 387: 98-108. PMID 19268337 DOI: 10.1016/J.Virol.2009.01.013 |
0.567 |
|
| 2009 |
Smith DM, Zárate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman DD, Frost SD, Ellis RJ. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 385: 204-8. PMID 19100592 DOI: 10.1016/J.Virol.2008.11.010 |
0.556 |
|
| 2008 |
Joos B, Fischer M, Kuster H, Pillai SK, Wong JK, Böni J, Hirschel B, Weber R, Trkola A, Günthard HF. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences of the United States of America. 105: 16725-30. PMID 18936487 DOI: 10.1073/Pnas.0804192105 |
0.454 |
|
| 2008 |
Kosakovsky Pond SL, Poon AF, Zárate S, Smith DM, Little SJ, Pillai SK, Ellis RJ, Wong JK, Leigh Brown AJ, Richman DD, Frost SD. Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Statistics in Medicine. 27: 4779-89. PMID 18381707 DOI: 10.1002/Sim.3192 |
0.598 |
|
| 2008 |
Pilcher CD, Wong JK, Pillai SK. Inferring HIV transmission dynamics from phylogenetic sequence relationships. Plos Medicine. 5: e69. PMID 18351799 DOI: 10.1371/Journal.Pmed.0050069 |
0.458 |
|
| 2008 |
Pillai SK, Wong JK, Barbour JD. Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology. 5: 26. PMID 18339206 DOI: 10.1186/1742-4690-5-26 |
0.463 |
|
| 2007 |
Willberg CB, Pillai SK, Sharp ER, Rosenberg MG, Agudelo JD, Barbour JD, Nixon DF. Rational peptide selection to detect human immunodeficiency virus type 1-specific T-cell responses under resource-limited conditions. Clinical and Vaccine Immunology : Cvi. 14: 785-8. PMID 17409221 DOI: 10.1128/Cvi.00048-07 |
0.418 |
|
| 2007 |
Noviello CM, Pond SL, Lewis MJ, Richman DD, Pillai SK, Yang OO, Little SJ, Smith DM, Guatelli JC. Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1. Journal of Virology. 81: 4776-86. PMID 17329339 DOI: 10.1128/Jvi.01793-06 |
0.504 |
|
| 2006 |
Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 355: 1-5. PMID 16962152 DOI: 10.1016/J.Virol.2006.08.009 |
0.568 |
|
| 2006 |
Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain : a Journal of Neurology. 129: 1872-83. PMID 16735456 DOI: 10.1093/Brain/Awl136 |
0.597 |
|
| 2006 |
Coleman SH, Madrid R, Van Damme N, Mitchell RS, Bouchet J, Servant C, Pillai S, Benichou S, Guatelli JC. Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif. Journal of Virology. 80: 1837-49. PMID 16439540 DOI: 10.1128/Jvi.80.4.1837-1849.2006 |
0.322 |
|
| 2005 |
Pillai SK, Kosakovsky Pond SL, Woelk CH, Richman DD, Smith DM. Codon volatility does not reflect selective pressure on the HIV-1 genome. Virology. 336: 137-43. PMID 15892955 DOI: 10.1016/J.Virol.2005.03.014 |
0.543 |
|
| 2005 |
Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology. 79: 1772-88. PMID 15650202 DOI: 10.1128/Jvi.79.3.1772-1788.2005 |
0.6 |
|
| 2005 |
Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. Journal of Virology. 79: 1734-42. PMID 15650198 DOI: 10.1128/Jvi.79.3.1734-1742.2005 |
0.574 |
|
| 2004 |
Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nature Structural & Molecular Biology. 11: 435-42. PMID 15098018 DOI: 10.1038/Nsmb758 |
0.541 |
|
| 2003 |
Kunstman KJ, Puffer B, Korber BT, Kuiken C, Smith UR, Kunstman J, Stanton J, Agy M, Shibata R, Yoder AD, Pillai S, Doms RW, Marx P, Wolinsky SM. Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea. Journal of Virology. 77: 12310-8. PMID 14581567 DOI: 10.1128/Jvi.77.22.12310-12318.2003 |
0.381 |
|
| 2003 |
Ali A, Pillai S, Ng H, Lubong R, Richman DD, Jamieson BD, Ding Y, McElrath MJ, Guatelli JC, Yang OO. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations. Journal of Immunology (Baltimore, Md. : 1950). 171: 3999-4005. PMID 14530319 DOI: 10.4049/Jimmunol.171.8.3999 |
0.538 |
|
| 2003 |
Pillai S, Good B, Richman D, Corbeil J. A new perspective on V3 phenotype prediction. Aids Research and Human Retroviruses. 19: 145-9. PMID 12643277 DOI: 10.1089/088922203762688658 |
0.532 |
|
| 2003 |
Pillai S, Good B, Richman D, Corbeil J. Sequence Note: A New Perspective on V3 Phenotype Prediction Aids Research and Human Retroviruses. 19: 347-347. DOI: 10.1089/088922203764969564 |
0.413 |
|
| 2002 |
Kalish ML, Korber BT, Pillai S, Robbins KE, Leo YS, Saekhou A, Verghese I, Gerrish P, Goh CL, Lupo D, Tan BH, Brown TM, Chan R. The sequential introduction of HIV-1 subtype B and CRF01AE in Singapore by sexual transmission: accelerated V3 region evolution in a subpopulation of Asian CRF01 viruses. Virology. 304: 311-29. PMID 12504572 DOI: 10.1006/Viro.2002.1691 |
0.352 |
|
| 2001 |
Nair MPN, Mahajan S, Chadha KC, Nair NM, Hewitt RG, Pillai SK, Chadha P, Sukumaran PC, Schwartz SA. Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients Advances in Experimental Medicine and Biology. 493: 235-240. PMID 11727771 DOI: 10.1007/0-306-47611-8_28 |
0.333 |
|
| Show low-probability matches. |